The fungal metabolite, brefeldin A (BFA), is known to inhibit guanine nucleotide exchange on the ADP-ribosylating factors that are involved in vesicle membrane trafficking. Here, we investigated the action of BFA on Ca 2؉ -regulated exocytosis in single rat adrenal chromaffin cells. Incubation of chromaffin cells with BFA (1 or 10 M) for 2 h effectively disrupted the Golgi membranes but did not affect the pattern of catecholamine release triggered by high extracellular K ؉ , which was monitored with carbon fiber amperometry along with cytosolic Ca 2؉ measurement. The BFA treatment, however, increased the mean quantal size of catecholamine-containing vesicles and the occurrence of amperometric events with a "foot" or "stand alone" signal (which reflects sluggish or incomplete dilation of the fusion pore). To examine whether BFA altered the Ca 2؉ -dependence of exocytosis, we employed the whole-cell recording technique in conjunction with the capacitance measurement to measure exocytosis evoked from the entire cell during voltage-gated Ca 2؉ entry. Our results suggested that BFA treatment did not alter either the initial rate of capacitance increase or the total amount of capacitance increase. Therefore, in chromaffin cells, BFA treatment affects Ca 2؉ -regulated exocytosis predominantly by increasing the quantal size and by slowing the fusion kinetics of some vesicles.
The fungal metabolite brefeldin A (BFA) 1 has been reported to disassemble the Golgi apparatus to form tubules, leading to the return of the Golgi membrane to the endoplasmic reticulum (1, 2) . This effect of BFA is at least partially mediated via the inhibition of guanine nucleotide exchange activity of a class of small monomeric GTP-binding proteins called ADP-ribosylating factors (ARFs) (3, 4) . In mammalian cells, there are at least six forms of ARF proteins. Among the ARF proteins, ARF1 is localized in the Golgi apparatus and is postulated to be involved in the recruitment of cytosolic coat proteins to membranes during transport vesicle formation (5) . The functions of the other ARFs are less well studied but may include regulation of phospholipase D (6, 7) and exocytosis (8) .
Other than the disassembly of the Golgi apparatus, BFA has been reported to inhibit peptide or protein secretion (9, 10) and in vitro formation of synaptic vesicles (11) . These actions were postulated to be secondary to the effect of BFA on membrane trafficking. BFA has also been reported to have actions that may be unrelated to membrane trafficking. For example, Ca 2ϩ -dependent exocytosis in rat melanotropes was inhibited by intracellular dialysis of BFA (10 M) , and this acute effect could be mimicked by intracellular dialysis of peptide fragment derived from residues 46 -61 of ARF (12) . In rat intestinal smooth muscle cells, BFA (150 M) reversibly inhibited the voltagegated Ca 2ϩ current (13) . In planar lipid bilayer, BFA has also been reported to cause formation of small (Ͻ15-picosiemens) cation channels (14) .
Here we have employed carbon fiber amperometry to examine the effects of BFA on quantal catecholamine release from rat chromaffin cells. We have also measured [Ca 2ϩ ] i and membrane capacitance simultaneously to examine whether BFA affects Ca 2ϩ -dependent exocytosis. Under the condition that BFA had clearly disassembled the Golgi apparatus, we found that BFA increased the quantal size of catecholamine release and dramatically increased the proportion of "stand alone signals," which probably arise from slow release of catecholamine via fusion pores that never dilate completely. However, BFA had no significant effects on the Ca 2ϩ dependence of exocytosis.
EXPERIMENTAL PROCEDURES
Chemicals-BFA (Calbiochem-Novabiochem) was kept as stock solution (10 mM) in ethanol and stored at Ϫ20°C. Immediately before use, BFA was diluted to 1 or 10 M with Dulbecco's modified Eagle's medium supplemented with 10% horse serum (Life Technologies, Inc.). C 6 -NBDceramide and indo-1 were purchased from Molecular Probes, Inc. (Eugene, OR). Indo-1FF was purchased from Teflabs (Austin, TX). Collagenase, deoxyribonuclease, hyaluronidase, and concanavalin A were purchased from Sigma.
Isolation and Primary Culture of Rat Adrenal Chromaffin Cells-Rat chromaffin cells were isolated and cultured as described previously (15) . Briefly, adrenal medullas were removed from male Sprague Dawley rats (200 -250 g) killed with halothane in accordance with the standards of the Canadian Council on Animal Care. The medullas were dissociated enzymatically in a modified Hanks' solution containing collagenase type I (3.0 mg/ml), hyaluronidase type I-S (2.4 mg/ml), and deoxyribonuclease type I (0.2 mg/ml) for 30 min at 37°C. Single chromaffin cells were plated on glass coverslips coated with either 1% gelatin and 1.6 mg/ml concanavalin A or 0.25 mg/ml poly-L-lysine. The cells were maintained in standard culture in Dulbecco's modified Eagle's medium supplemented with 10% horse serum, 50 units/ml penicillin G, and 50 g/ml streptomycin. All electrochemical and electrophysiological recordings were performed at room temperature (21-24°C) on cells maintained in culture for 1-4 days.
Staining of the Golgi Apparatus-The Golgi stacks of living chromaffin cells were stained by C 6 -NBD-ceramide, a fluorescent lipid that has been demonstrated to label the Golgi apparatus in living cells reliably (16) . Briefly, rat chromaffin cells were incubated with C 6 -NBD-ceramide (10 mmol/liter) in Dulbecco's modified Eagle's medium containing 0.68 mg/ml bovine serum albumin for 10 min at 37°C. After washing off the C 6 -NBD-ceramide, the cells were bathed in standard bath solution (see below) for 30 min at 37°C. The stained cells were then observed under a fluorescent microscope via a 63ϫ objective. For BFA pretreatment, the cells were first incubated with 1 or 10 M BFA for 2 h at 37°C before staining with C 6 -NBD-ceramide. Otherwise, BFA was applied to stained cells acutely for the duration indicated.
Electrochemical Detection of Catecholamine Release-Amperometry with carbon fiber electrodes was performed on single chromaffin cells to monitor real-time release of catecholamine molecules during exocytosis of vesicle (17) . The fabrication of carbon fiber electrodes (tip diameter of 7 m) was as described in Refs. 18 and 19 . During the recording, the tip of the carbon fiber electrode was positioned such that it was touching the cell surface. A 700-mV potential (D.C.) was applied to the carbon fiber electrode, using a VA-10 Voltammeter (NPI Electronic GmbH, Tamm, Germany). The amperometric current was filtered at 1 kHz, stored on videocassette recorder tapes with a NeuroData PCM recorder (Neuro Data Corp., New York, NY), and digitized at 10 kHz later. Cells were initially bathed in the standard bath solution containing 150 mM NaCl, 2.5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 8 mM glucose, and 10 mM Na-HEPES (pH 7.4). To trigger catecholamine release, cells were perfused with 50 mM KCl isotonic solution (the [K ϩ ] in the standard bath solution was increased to 50 mM by decreasing equal [Na ϩ ]). Amperometric events were analyzed with software developed by Drs. Robert H. Chow and Zhuan Zhou (19) .
Microfluorometry-For combined fluorimetry and electrochemical measurement, cells were incubated with 5 M indo-1-AM in the standard bath solution for 30 min at 37°C, followed by at least 15 
where all three calibration constants, R min , R max , and K* were determined in situ for both indo-1 and indo-1-FF by dialyzing various solutions of known Ca 2ϩ concentration into cells as described previously (21, 22) . The values for R min , R max , and K* were 0.27, 2.82, and 2.54 M for indo-1 and 0.21, 1.49, and 29.4 M for indo-1-FF.
Electrophysiological Recording-Membrane currents were recorded with the whole-cell gigaseal method (23) using an EPC-7 amplifier. Pipettes were made from hematocrit glass (VWR Scientific, London, Ontario, Canada), and the resistance was 2-3 megaohms after being filled with pipette solution. In experiments where exocytosis was triggered via short depolarizing voltage steps, [Ca 2ϩ ] i in the standard bath solution was increased to 10 mM. In addition, tetradotoxin (0.5 M) and apamin (0.4 M) were included in the bath solution to block Na ϩ currents and the small conductance Ca 2ϩ -activated K ϩ currents, respectively. The standard pipette solution contained 135 mM cesium aspartate, 10 mM tetraethylammonium chloride, 20 mM HEPES, 3 mM MgCl 2 , 2 mM Na 2 -ATP, 0.3 mM GTP, and 0.1 mM indo-1 or indo-1-FF (pH 7.4).
To measure membrane capacitance changes (⌬C m ), which reflected the addition of plasma membrane and hence exocytosis at high temporal resolution, we employed a software-based phase-sensitive detector (Pulse Control) (24) developed by Drs. Jack Herrington and Richard Bookman (University of Miami, Miami, FL). A 30-mV, 822-Hz sinusoidal wave was added to the holding potential (Ϫ90 mV D.C.). The resulting current signal at two orthogonal phase angles was analyzed to generate an output for changes in cell capacitance (⌬C m ) and another output, ⌬G, which reflects changes in membrane conductance, electrode seal, and series resistance. To reduce contamination in the capacitance signal due to the gating of Na ϩ channels (25) , all capacitance recordings were subtracted with the capacity transient in response to a 5-ms depolarization delivered to the same cell.
Statistical Analysis-Each treatment with BFA was compared with control cells from the same batch(es) of culture. On each experimental day, recordings were performed alternately on BFA-treated and control cells. The number of cells as well as the number of cultures pooled for each comparison are indicated in the figure legends. All mean values are given as mean Ϯ S.E. In order to determine whether the BFA effect is statistically significant, a Student's t test for two independent populations was performed on data collected from BFA-treated cells and control cells of the same batches. All t values with (p Ͻ 0.05) were considered statistically significant.
RESULTS

Disassembly of the Golgi Apparatus by BFA-
We have chosen to examine the effects of BFA while the Golgi apparatus was disassembled. To determine the experimental conditions under which BFA would cause the disassembly of the Golgi apparatus, we employed a fluorescent ceramide (C 6 -NBD-ceramide) that reliably labels the Golgi membranes in living cells (16) . In control chromaffin cells, the fluorescence of C 6 -NBDceramide was always confined to a small region adjacent to the nucleus. Acute application of BFA (10 M) for 5-10 min at room temperature did not cause any significant change in the pattern of staining. In contrast, in cells pretreated with 1 or 10 M BFA for 2 h (at 37°C), the fluorescence became dispersed all over the cytoplasm (except the nucleus). Thus, a 2-h incubation with BFA at 37°C was sufficient to disrupt the Golgi apparatus in most chromaffin cells (Ͼ90%). Although BFA was removed from the cells during the time of staining (40 min at 37°C), the dispersed fluorescence persisted throughout our observation (30 min, at room temperature). Thus, it is likely that, at room temperature, the BFA-induced morphological changes in the Golgi stacks can persist for at least 1 h following BFA removal. In this study, we performed electrochemical and/or electrophysiological experiments on cells treated with BFA under three conditions. First, we applied BFA acutely during the experiment (3-5 min at room temperature) to examine whether BFA had any acute effects on quantal release or exocytosis before changes in the Golgi morphology could occur. Second, we pretreated the cells with BFA for 2 h (at 37°C) and then performed measurements within 1 h (at room temperature) following BFA removal to examine the persistent effects of BFA. Last, we performed experiments on cells continuously exposed to BFA (2 h at 37°C, followed by Ͻ1 h at room temperature) to investigate whether the continuous presence of BFA might have more prominent effects. Fig. 1 shows a typical recording obtained from a cell pretreated with 10 M BFA for 2 h. The resting [Ca 2ϩ ] i in control cells was typically between 50 and 300 nM, and all of the BFA treatments did not affect this value in the vast majority of the cells (95-99% (17) . Similar patterns of [Ca 2ϩ ] i rise and amperometric signals were observed in control cells (n ϭ 28), cells acutely exposed to 10 M BFA (n ϭ 6), cells pretreated with 1 (n ϭ 8) or 10 M BFA (n ϭ 7), and cells exposed continuously to BFA 10 M (n ϭ 6). The frequency and total number of amperometric spikes recorded in the first few minutes varied among cells. Typically, during the first 2 min of stimulation with high extracellular [K ϩ ], 100 -400 amperometric spikes could be recorded from an individual cell.
BFA Treatment Increases the Quantal Size of Some Catecholamine-containing Vesicles-
The similar pattern of [Ca 2ϩ ] i rise and amperometric signals in control and BFA-treated cells during application of high [K ϩ ] suggested that BFA treatment had no dramatic effect on the voltage-gated Ca 2ϩ entry and the triggering of catecholamine release. However, detailed analysis of individual amperometric spikes suggested that BFA might have some major actions on the quantal release of catecholamines. Fig. 2 plots the frequency histograms of quantal charge (time integral of individual amperometric spike) in control cells, and in cells pretreated with 1 or 10 M BFA. Note that in cells pretreated with 10 M BFA, the proportion of amperometric spikes with large quantal charge (Ͼ2 pC) was increased. Concomitantly, the proportion of amperometric spikes with small charge (Ͻ0.2 pC) was reduced. The effect of 10 M BFA pretreatment could be clearly observed in the cube-root transformation (charge 1 ⁄3 ; Fig. 2B ), or the log transformation (log(charge); Fig. 2C ), of the quantal charge histogram. Both of these transformations are expected to convert the quantal charge distribution into a normal distribution (26, 27) . Note that in comparison with the controls, the mean value of quantal charge 1 ⁄3 in cells pretreated with 10 M BFA was increased by ϳ1.2-fold (from 0.66 Ϯ 0.01 to 0.78 Ϯ 0.01 pC 1 ⁄3 ), and the log (charge) was increased by 0.22 log unit (from Ϫ0.63 Ϯ 0.02 to Ϫ0.41 Ϯ 0.02). These correspond to a ϳ1.7-fold increase in mean quantal charge after 10 M BFA pretreatment. Fig. 3 summarizes the mean values of quantal charge 1 ⁄3 of control cells and cells subjected to different BFA treatments. Note that in comparison with the controls, pretreatment or continuous exposure of 10 M BFA increased the mean of quantal charge 1 ⁄3 by more than 1.2-fold. However, acute application of 10 M BFA had no significant effect in the mean quantal charge. These results suggest that prolonged BFA treatment is needed to alter the quantal charge in chromaffin cells. The similarity between the BFA-pretreated cells and the continuously treated cells suggests that at room temperature, the BFA-induced increase in quantal charge cannot be reversed in 1 h. This effect of BFA also appeared to be concentrationdependent. In cells pretreated with 1 M BFA (Fig. 2) , there was an increase in the proportion of spikes with large total charge, but neither the cube root (0.67 Ϯ 0.01 pC 1 ⁄3 ) nor the log (Ϫ0.62 Ϯ 0.02) of quantal charge showed any significant difference from those in control cells. Fig. 4 shows the amplitude, rise time (the time between 50 and 90% of the peak amplitude), and the half-width (duration of the amperometric signal at 50% of its peak amplitude) of the control and BFA-pretreated cells. Note that in cells pretreated with 10 M BFA, there was an increase in the proportion of amperometric spikes with large amplitude (e.g. Ͼ300 pA; Fig.  4A ), slow rise time (e.g. Ͼ3 ms; Fig. 4B ), and long half-width (e.g. Ͼ10 ms; Fig. 4C ). Similar effects were also observed in cells exposed continuously to 10 M BFA but not for cells acutely exposed to 10 M BFA (data not shown). As in Fig. 2 , the change in cells pretreated with 1 M BFA was less obvious. Overall, the patterns of change caused by BFA are consistent with an increase in the amount of catecholamine released during an average spike (quantum) and in the proportion of quanta with a slower kinetics of release. (28 -31) , some of the amperometric spikes we recorded are preceded by a "foot" signal (Fig. 5A ), reflecting transmitter leakage through an early fusion pore that does not dilate immediately. In control cells, the occurrence of the foot signals was 19 Ϯ 2% of all amperometric events. Interestingly, BFA treatment increased the occurrence of the foot signals (summarized in Fig. 5B ). This increase is statistically significant in cells exposed to 10 M BFA acutely, continuously, or in pretreatment. Previous electrochemical studies also demonstrated the existence of stand alone signals in amperometry (Fig. 5C) , which represent openings of fusion pores that never dilate but flicker before closing (19, 30, 31) . These stand alone signals typically have a rapid rise time and have rapid current fluctuations that clearly exceed the base-line noise. Except for the absence of a following spike, they are similar to foot signals in both temporal and amplitude characteristics. Under normal conditions, the stand alone signals are rarely observed in chromaffin cells (0.8 Ϯ 0.3% of all amperometric signals in our control cells; also see Ref. 30 ). BFA treatments (10 M; pretreatment or continuous treatment), however, significantly increased the frequency of the stand alone signals (Fig. 5D) .
BFA Treatment Alters the Fusion Kinetics of Some Catecholamine-containing Vesicles-Consistent with previous studies in chromaffin cells and other catecholamine-secreting cells
BFA Treatment Has Little or No Effect on the Ca 2ϩ
Dependence of Exocytosis-The results above suggested that BFA caused a change in the quantal size as well as the kinetics of catecholamine release in some vesicles. We further examined whether BFA affected the Ca 2ϩ dependence of exocytosis. In this series of experiments, single chromaffin cells were wholecell voltage-clamped at Ϫ90 mV (D.C.). Exocytosis was triggered by a 250-or 500-ms depolarization to ϩ10 mV to stimulate extracellular Ca 2ϩ entry via voltage-gated Ca 2ϩ channels. The rise in cell-averaged [Ca 2ϩ ] i was measured by the ratiometric fluorescent indicator indo-1 or indo-1-FF, while the triggered exocytosis was monitored as changes in membrane capacitance. Fig. 6 shows a typical experiment in control cells. During the depolarization, Ca 2ϩ current (I Ca ; peak amplitude, ϳ250 pA) was activated, and it was accompanied by a rise in [Ca 2ϩ ] i and an increase in membrane capacitance (⌬C m ), which reflects exocytosis. Following the termination of the voltage step, [Ca 2ϩ ] i decayed slowly and remained above 1 M for Ͼ3 s. Meanwhile, the membrane capacitance continued to increase slowly for ϳ300 ms and then started to decline. Note that the gradual decrease in ⌬C m actually overshot the original resting value. This pattern of ⌬C m decrease has been interpreted as endocytosis of the "excessive retrieval" type (32, 33) and is typically observed following a large [Ca 2ϩ ] i elevation. In our analysis, we used both the capacitance increase during the depolarizing pulse (referred to as the "C m jump") and the "total C m rise" (the sum of C m jump and any C m rise following the depolarizing pulse) as indices of exocytosis evoked by a single depolarization (Fig. 5) . Similar experiments were repeated on cells treated with BFA.
We first examined Ca 2ϩ -dependent exocytosis in cells pretreated with 1 M BFA, a treatment that clearly disrupted the Golgi apparatus but caused no significant increase in quantal A, example of an amperometric event with a preceding foot signal, which reflects catecholamine leakage through a narrow fusion pore before its complete dilation. B, the proportion of amperometric events with a preceding foot signal was normalized to that of control from the same cell batch(es). The asterisks denote BFA treatments that cause significant increase on the frequency of foot signals when compared with their corresponding controls. C, example of a stand alone signal, which reflects incomplete catecholamine release through a flickering fusion pore that does not dilate. Note that the stand alone signal is similar to a foot signal in rise time, duration, and amplitude, but it is not followed by a complete amperometric event. D, the proportion of stand alone signals is normalized to that of control from the same cell batch. The asterisks denote BFA treatments that cause significant increase in the occurrence of stand alone signals. In B and D, the data came from the same batch(es) of cultures as described in Fig. 3 . The numbers of cells for each comparison (control:treatment) are also as described in Fig. 3 . Our amperometry experiments (e.g. Fig. 1 ) have shown that during continuous perfusion of high [K ϩ ], BFA-treated cells could release catecholamine for many minutes. This suggested that BFA might not have dramatic effects on the mobilization of vesicle in the time course of many minutes. However, the amperometry method only monitors catecholamine secretion from a fraction of the cell surface, and previous studies in chromaffin cells (35) have also suggested that the sites of catecholamine release might be unevenly distributed on the cell surface. Therefore, it is hard to rely on amperometry to get a quantitative comparison of secretion from different groups of cells. To further examine whether BFA affected vesicle mobilization, we measured the cumulative increase in capacitance during a train of depolarization steps. In this set of experiments, the cell was held at Ϫ90 mV (D.C.). A train of 15 depolarization steps (held at ϩ10 mV for 50 ms in each step) was delivered at 4 Hz. An example of such an experiment on a cell pretreated with 1 M BFA was shown in Fig. 8, A and B . In this cell, the train of depolarization steps triggered a [Ca 2ϩ ] i rise as well as increases in C m . Fig. 8C plots the cumulative exocytosis versus the peak [Ca 2ϩ ] i in both the control cells and cells pretreated with 1 M BFA. Note that at comparable peak [Ca 2ϩ ] i , no significant difference could be detected between the two groups. We also examined whether BFA affected the initial rate of exocytosis by measuring the rate of C m jump during the first 50-ms depolarization (Fig. 8D) . Since the Ca 2ϩ entry during the brief depolarization (50 ms) might not be distributed uniformly throughout the cell volume, we have normalized the Ca 2ϩ entry (time integral of I Ca ) to the cell surface area (initial cell membrane capacitance) instead of the cell volume. Fig. 8D shows that at comparable Ca 2ϩ entry, the initial rate of exocytosis was not significantly affected by BFA. Thus, 1 M BFA pretreatment had no significant effect on either the cumulative Ca 2ϩ -dependent exocytosis or the initial rate of Ca 2ϩ -dependent exocytosis in chromaffin cells.
We have shown earlier that a continuous exposure of 10 M BFA not only disrupted the Golgi apparatus but also increased the mean quantal charge in chromaffin cells (Fig. 3) . To examine whether such a BFA treatment can affect Ca 2ϩ -dependent exocytosis, we repeated the train of depolarization experiments (similar to Fig. 8, A and B) on cells continuously exposed to 10 M BFA. Fig. 8 , E and F, shows that even in cells treated continuously with 10 M BFA, there was no statistically significant change in the Ca 2ϩ dependence of the cumulative exocytosis or the initial rate of exocytosis. These results further confirm that BFA treatment has little effect on Ca 2ϩ -dependent exocytosis. ] i remained elevated, and the membrane capacitance continued to increase slightly (denoted by the difference between arrows b and c). Therefore, in this study, the total C m rise (denoted by the difference between arrows a and c) was measured as the sum of the C m jump during the depolarization and the subsequent C m rise. Following exocytosis, the membrane capacitance gradually decreased and eventually fell below its initial value, reflecting endocytosis of the "excessive retrieval" type. ment or continuous treatment for 2 h tended to increase the quantal size of some vesicles. This trend was clear for the higher BFA concentration (10 M), which almost doubled the mean quantal size (Figs. 2 and 3 ). This change in the catecholamine content in single vesicles may be due to an alteration in the concentration of catecholamine and/or the vesicle volume. BFA is known to inhibit the formation of coated vesicles, hence causing a misregulation of vesicle budding. Thus, it is possible that the budding of some catecholamine vesicles either at the plasma membrane or at internal membranes is misregulated by the BFA treatment, and this in turn leads to the formation of larger vesicles. Alternatively, fusion between catecholamine-containing vesicles may occur when BFA disrupts the membrane trafficking pathway. In theory, an increase in the average size of vesicles may be detected as a larger increase in capacitance for identical Ca 2ϩ entry during activation of voltage-gated Ca 2ϩ channels (i.e. if the same number of vesicles is triggered to undergo exocytosis). However, in cells continuously treated with 10 M BFA for 2 h (the experimental condition that caused the largest increase in quantal size of catecholamine vesicles), we detected no significant change in either the cumulative exocytosis or the initial rate of exocytosis ( 
